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2INTRODUCTION
The purpose of the work carried under this interchanges was to support the development
of space flight biotechnology experiments in the areas of immunology and hematopoiesis to
facilitate the commercial development of space. The studies involved the interaction and
development of experiments with biotechnology companies for necessary ground-based studies
to allow the development of flight studies.
The thrust of the work was to develop experiments with the Chiron Corporation and
Bioserve involving the use of interleukin-2 to modulate the effects of spaceflight on immune
responses. Spaceflight has been shown to have multiple effects on immune responses (1).
Interleukin-2 is an immunoregulator that could have potential to counter some of the alterations
induced in immune responses by spaceflight (1).
To test this possibility before flight, rats were suspended antiorthostatically (2) and
treated with interleukin-2. Antiorthostatic suspension is a model for some of the effects of
spaceflight on immune responses (2). The interleukin-2 was given to see if it could alter some of
the effects of suspension. This was achieved. As a result of these studies, two flight
experiments were developed and flown with the Chiron Corp. And Bioserve to determine if use
of interleukin-2 could prevent or attenuate the effects of space flight on immune responses.
3METHODS
Rats were antiorthostatically suspended by the tail (2). At the commencement of
suspension, some of the rats were treated with various doses of interleukin-2, a product of the
Chiton Corporation, and control rats were treated with placebo. Other control rats were
maintained in normal vivarium housing. At the end of the suspension period, immunological
parameters of the rats were examined. These experiments were carried out more than 3 times.
Two sets of immunological parameters were examined. The first was the ability of
interleukin-2 to prevent the loss of the ability of bone marrow cells from suspended to respond to
granulocyte-macrophage colony stimulating factor (3). After suspension, femurs were removed
from the rats and bone marrow was obtained The bone marrow was placed in a semi-solid
medium in tissue culture dishes. The medium also contained granulocyte-macrophage colony
stimulating factors. Normally, the colony stimulating factor would cause colonies to form after at
least one week of incubation, and suspension, as space flight, would inhibit this (3). After the
incubation period, the number of colonies was determined microscopically.
The second parameter was interferon production, which has been shown to be altered by
space flight and suspension (4). Spleens were removed from the rats after suspension and
passed through screens to allow development of single cells cultures. The cultures were
challenged with interferon inducers, and allowed to remain in culture for interferon-alpha/beta and
interferon-gamma production. The culture supernatant fluids were then analyzed for interferon
levels (4).
Additional experiments were attempted to determine leukocyte subset distribution by flow
cytometry (3). These results did not appear to be reliable, and the experiments were dropped
from actual flight studies.
4RESULTS AND DISCUSSION
The results of this study indicated that treatment of rats with interleukin-2 reduced the
inhibitory effects of suspension on the ability of bone marrow cells to respond to granulocyte-
macrophage colony stimulating factor. Additionally, a trend to improvement of the interferon
response was also observed. No useful data on flow cytometry were observed. In view of the
results of these studies, two space flight experiments using interleukin-2 were designed and
carried out with the Chiron Corp. And Bioserve.
PUBLICATIONS
A manuscript is currently in preparation. It will be forwarded when available.
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